Studies have shown that in patients with COPD, with the increase of the inflammation indicators, C-reactive protein (CRP) and procalcitonin (PCT) increase, and HDAC2 levels gradually decrease. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.